Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China

Abstract T lymphoblastic leukemia /lymphoma (T-ALL/LBL) is a rare and highly aggressive neoplasm of lymphoblasts. We evaluated 195 T-ALL/LBL adolescent and adult patients who received ALL-type chemotherapy alone (chemo,n = 72) or in combination with autologous hematopoietic stem cell transplantation...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Luo, Lan [verfasserIn]

Jiao, Yang [verfasserIn]

Li, Yan [verfasserIn]

Yang, Ping [verfasserIn]

Gao, Jinjie [verfasserIn]

Huang, Sai [verfasserIn]

Huang, Wenyang [verfasserIn]

Wang, Jijun [verfasserIn]

Dong, Fei [verfasserIn]

Ke, Xiaoyan [verfasserIn]

Zou, Dehui [verfasserIn]

Gao, Chunji [verfasserIn]

Jing, Hongmei [verfasserIn]

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2024

Schlagwörter:

T lymphoblastic leukemia /lymphoma (T-ALL/LBL)

Autologous hematopoietic stem cell transplantation (auto-HSCT)

Allogeneic hematopoietic stem cell transplantation (allo-HSCT)

Minimal residual disease (MRD)

Early T-cell precursor (ETP)

Anmerkung:

© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Übergeordnetes Werk:

Enthalten in: Annals of hematology - Springer Berlin Heidelberg, 1955, 103(2024), 6 vom: 06. Apr., Seite 2073-2087

Übergeordnetes Werk:

volume:103 ; year:2024 ; number:6 ; day:06 ; month:04 ; pages:2073-2087

Links:

Volltext

DOI / URN:

10.1007/s00277-024-05719-7

Katalog-ID:

SPR055828868

Nicht das Richtige dabei?

Schreiben Sie uns!